Quality of life of Tunisian patients with lung cancer: descriptive study.
No previous study has set as primary goal the evaluation of the quality of life (QOL) of Tunisian patients with lung cancer (LC). To evaluate the QOL of Tunisian patients with LC. This was a cross-sectional descriptive study. QOL of 100 patients with LC (90 men) was evaluated via the QLQ-C30 and QLQ-LC13 questionnaires. QLQ-C30 data were compared with international reference values. 40, 38, 7 and 15% of patients had, adenocarcinoma, squamous cell carcinoma, large cell and small cell LC, respectively. 72, 20 and 8% of patients had received chemotherapy, combination of chemotherapy and surgery or radiotherapy, respectively. The means±SDs of the QLQ-C30 were 3717 (QOL), 5121 (physical activity), 3921 (life role activity), 9113 (cognitive activity), 6622 (emotional activity), 2720 (social activity), 5517 (fatigue), 5120 (pain), 820 (nausea/vomiting), 4221 (dyspnea), 6623 (insomnia), 5125 (anorexia), 4932 (constipation), 1021 (diarrhea) and 7173 (financial problems). The scores means±SDs of dyspnea, cough, hemoptysis, sore mouth and tongue, dysphagia, peripheral neuropathy, alopecia, chest pain, pain in arm or shoulder, and other pain sites were, 5116, 4523, 1319, 1819, 1017, 3430, 1522, 4720, 4534, and 1419, respectively. Comparison of QLQ-C30 data with international reference values showed an alteration of all scores except of those of emotional activity, nausea/vomiting, dyspnea and diarrhea. Tunisian patients with LC had poor QOL.